Literature DB >> 14567991

Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin.

Eliska Svastová1, Norbert Zilka, Miriam Zat'ovicová, Adriana Gibadulinová, Fedor Ciampor, Jaromír Pastorek, Silvia Pastoreková.   

Abstract

Carbonic anhydrase IX (CA IX) is a cancer-associated transmembrane isoform of zinc metalloenzymes that catalyse interconversion between carbon dioxide and bicarbonate. CA IX is strongly induced by tumor hypoxia and has been proposed to participate in acidification of tumor microenvironment and in cell adhesion. To elucidate the cell adhesion-related role of CA IX, we investigated its subcellular localization and relationship to E-cadherin, a key adhesion molecule whose loss or destabilization is linked to tumor invasion. For this purpose, we generated MDCK cells with constitutive expression of human CA IX protein. During the monolayer formation, CA IX was localized to cell-cell contacts and its distribution in lateral membranes overlapped with E-cadherin. Calcium switch-triggered disruption and reconstitution of cell contacts resulted in relocalization of both CA IX and E-cadherin to cytoplasm and back to plasma membrane. A similar phenomenon was observed in hypoxia-treated and reoxygenated cells. Moreover, CA IX-expressing MDCK cells exhibited reduced cell adhesion capacity and lower levels of Triton-insoluble E-cadherin. Finally, CA IX was found to coprecipitate with beta-catenin. We conclude that CA IX has a capacity to modulate E-cadherin-mediated cell adhesion via interaction with beta-catenin, which could be of potential significance in hypoxia-induced tumor progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567991     DOI: 10.1016/s0014-4827(03)00351-3

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  84 in total

1.  The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-catenin.

Authors:  Rachael Z Murray; Lachlan A Jolly; Stephen A Wood
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

2.  Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.

Authors:  Feray Kockar; Hatice Yildrim; Rahsan Ilikci Sagkan; Carsten Hagemann; Yasemin Soysal; Jelena Anacker; Ahmed Ayad Hamza; Dirk Vordermark; Michael Flentje; Harun M Said
Journal:  World J Clin Oncol       Date:  2012-06-10

3.  Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.

Authors:  Tania Fiaschi; Elisa Giannoni; Maria Letizia Taddei; Paolo Cirri; Alberto Marini; Gianfranco Pintus; Cristina Nativi; Barbara Richichi; Andrea Scozzafava; Fabrizio Carta; Eugenio Torre; Claudiu T Supuran; Paola Chiarugi
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

4.  Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model.

Authors:  Eun Ju Cho; Su Jong Yu; Kyungmin Kim; Heki Cho; Young Youn Cho; Yun Bin Lee; Jeong-Hoon Lee; Yoon Jun Kim; Hyewon Youn; Jung-Hwan Yoon
Journal:  J Bioenerg Biomembr       Date:  2019-02-12       Impact factor: 2.945

5.  Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.

Authors:  Elīna Zandberga; Pawel Zayakin; Artūrs Ābols; Dārta Pūpola; Pēteris Trapencieris; Aija Linē
Journal:  Cancer Biol Ther       Date:  2017-06-30       Impact factor: 4.742

6.  Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.

Authors:  Caroli Genis; Katherine H Sippel; Nicolette Case; Wengang Cao; Balendu Sankara Avvaru; Lawrence J Tartaglia; Lakshmanan Govindasamy; Chingkuang Tu; Mavis Agbandje-McKenna; David N Silverman; Charles J Rosser; Robert McKenna
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

7.  The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis.

Authors:  Kristiina Nordfors; Joonas Haapasalo; Miikka Korja; Anssi Niemelä; Jukka Laine; Anna-Kaisa Parkkila; Silvia Pastorekova; Jaromir Pastorek; Abdul Waheed; William S Sly; Seppo Parkkila; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-04-18       Impact factor: 4.430

8.  Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology.

Authors:  Chen Xu; Agnes Lo; Anuradha Yammanuru; Aimee St Clair Tallarico; Kristen Brady; Akikazu Murakami; Natasha Barteneva; Quan Zhu; Wayne A Marasco
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  Global transcriptional response to carbonic anhydrase IX deficiency in the mouse stomach.

Authors:  Heini Kallio; Mika Hilvo; Alejandra Rodriguez; Eeva-Helena Lappalainen; Anna-Maria Lappalainen; Seppo Parkkila
Journal:  BMC Genomics       Date:  2010-06-23       Impact factor: 3.969

10.  Induction of carbonic anhydrase IX by hypoxia and chemical disruption of oxygen sensing in rat fibroblasts and cardiomyocytes.

Authors:  Tereza Holotnakova; Attila Ziegelhoffer; Anna Ohradanova; Alzbeta Hulikova; Marie Novakova; Juraj Kopacek; Jaromir Pastorek; Silvia Pastorekova
Journal:  Pflugers Arch       Date:  2007-12-11       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.